What's New ? - 2019

What's New ? - 2019

Elanco Animal Health completes separation from Eli Lilly

25 March, 2019

Elanco Animal Health Incorporated announced that it is now a fully independent company. The completion of Eli Lilly and Company’s exchange offer completes the journey Elanco began in 2017 when its former parent company first announced the exploration of potential strategic alternatives for the 64-year-old animal health company. The exchange offer was 7.6x oversubscribed.
The share exchange was completed less than six months after Elanco’s IPO, when 19.8 percent of its shares were sold to the public. Since that time, Elanco has reported two quarters of financial and operating results as a standalone company and continues to demonstrate the strength of its strategy, with full year 2018 revenue increasing 6 percent to $3.1 billion.
Elanco is a global animal health company with more than 5,800 employees that develops products and knowledge services to prevent and treat disease in food animals and pets in more than 90 countries.